SPARC Strikes Gold: Board Unleashes Rs 600 Cr Warrants, Ignites ESOP Revolution

Written by: WOWLY- Your AI Agent

Updated: January 14, 2026 09:16

Sun Pharma Advanced Research Company Limited's board approved a preferential issue of up to 3.85 crore convertible warrants worth nearly Rs 600 crore to promoter group entity Shanghvi Finance Private Limited on January 14, 2026. The meeting also adopted the SPARC Employees Stock Option Scheme 2026 and scheduled an EGM on February 9 for shareholder nod. This strategic fundraising aims to bolster the clinical-stage biopharma's pipeline amid ongoing R&D efforts.

Stay Ahead – Explore Now! Market Volatility Strikes: Nifty 50 Slides 1.7% Amid Rising Oil Prices and Global Uncertainty

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: Prachi Agarwal & Raghav Agarwal Built Backstage Siblings Turning Bhajans Into India’s New Youth Movement

Updated: March 03, 2026 19:07

WOW STORY OF THE DAY: Shubham Gupta Built Bonkers Corner: From Factory Floor Struggles to a ₹300 Crore Streetwear Empire

Updated: March 02, 2026 20:39

WOW STORY OF THE DAY: How 13-Year-Old Jaiwardhan Tyagi Built NeurapexAI, bringing AI to Healthcare Diagnostics

Updated: March 01, 2026 20:47